AVLN
Avalyn Pharma Inc.Company Information
- Company Name
- Avalyn Pharma Inc.
- CIK
- CIK0001540171
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- AVLN: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- AVLN
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-05-01
- Last sale
- —
- Shares purchased (TTM)
- 1,388,888
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 40,810,370
- Shares outstanding
- 29,650,660
- Ownership
- 137.64%
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- 0.03%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||
| Cash And Cash Equivalents At Carrying Value | 264 | 92 | ||||||
| Marketable Securities Current | 88 | 31 | ||||||
| Prepaid Expense And Other Assets Current | 6 | 7 | ||||||
| Assets Current | 358 | 130 | ||||||
Assets Noncurrent | ||||||||
| Property Plant And Equipment Net | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 2 | 1 | ||||||
| Marketable Securities Noncurrent | 61 | - | ||||||
| Other Assets Noncurrent | 3 | 3 | ||||||
| Assets Noncurrent | 67 | 6 | ||||||
| Assets | 425 | 136 | ||||||
Liabilities Current | ||||||||
| Accounts Payable Current | 3 | 3 | ||||||
| Accrued Liabilities Current | 7 | 8 | ||||||
| Operating Lease Liability Current | 1 | 1 | ||||||
| Liabilities Current | 11 | 12 | ||||||
Liabilities Noncurrent | ||||||||
| Long Term Debt Noncurrent | 15 | 15 | ||||||
| Operating Lease Liability Noncurrent | 1 | 1 | ||||||
| Liabilities | 27 | 28 | ||||||
Stockholders Equity | ||||||||
| Preferred Stock Value | 0 | - | ||||||
| Common Stock Value | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 720 | 28 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -321 | -292 | ||||||
| Stockholders Equity | 398 | -264 | ||||||
| Liabilities And Stockholders Equity | 425 | 136 | ||||||
| Series C Preferred Stock | 0 | 0 | ||||||
| Preferred Stock Liquidation Preference Value | - | 373 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 10 | - | ||||||
| Preferred Stock Shares Issued | 0 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 700 | 585 | ||||||
| Common Stock Shares Issued | 44 | 1 | ||||||
| Shares Outstanding | 44 | 1 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialAvalyn Pharma Inc. (AVLN) — SEC Financial Statements & Analysis
Avalyn Pharma Inc. (AVLN) is a pharmaceutical preparations company, incorporated in DE. Avalyn Pharma Inc. trades on Nasdaq as: AVLN. Avalyn Pharma Inc. (AVLN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, Avalyn Pharma Inc. carries a market cap of $976.10M, a P/B ratio of 2.45x, and an enterprise value of $726.70M. On the balance sheet, it maintains a current ratio of 33.12x, a quick ratio of 32.60x, working capital of $347.18M, a debt-to-equity ratio of 0.07x, a debt ratio of 0.06, and net debt of $-249.40M. Figures sourced from SEC EDGAR.
- Market Cap
- $976.10M
- P/B TTM
- 2.45x
- Debt To Equity
- 0.07x
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Avalyn Pharma Inc. in?
Avalyn Pharma Inc. (AVLN) operates in the Pharmaceutical Preparations industry.
What exchange does AVLN trade on?
Avalyn Pharma Inc. (AVLN) trades on the Nasdaq.
Where is Avalyn Pharma Inc. incorporated?
Avalyn Pharma Inc. is incorporated in DE.
When was Avalyn Pharma Inc. (AVLN)'s most recent SEC filing?
Avalyn Pharma Inc. (AVLN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is AVLN's market cap?
Avalyn Pharma Inc. (AVLN) has a market capitalization of $976.10M as of 2026-06-30.